Thus, inhibiting the NAE by MLN4924 prevents destruction of numerous substrates of the CRLs, involved in cell proliferation and cancer pathways, such as not only CDT1 and p21, but also cyclins and checkpoint kinases [26, 39, 57, 58]. The gene discussed is PCNA; the disease is cancer.